The inhibitory activity (IC50) of GSK269962A on AML cells ranged from 0.61 to 1,337 nM (Supplementary Table S1), indicating that the sensitivity of different cell lines to ROCK1 inhibition varied greatly. The gene discussed is ROCK1; the disease is acute myeloid leukemia.